STAT3 and cancer: Napabucasin is a STAT3 inhibitor that mainly acts on cancer stem cells, but a quantitative proteomics analysis of the napabucasin-based PROTAC molecule XD2-149 revealed that XD2-149 significantly reduces the level of ZFP91 [43].